Latest News about LGVN
Recent news which mentions LGVN
34 Stocks Moving In Friday's Mid-Day Session
January 21, 2022
From Benzinga
From InvestorPlace
18 Stocks Moving in Friday's Pre-Market Session
January 21, 2022
From Benzinga
58 Biggest Movers From Yesterday
January 07, 2022
From Benzinga
33 Stocks Moving In Thursday's Mid-Day Session
January 06, 2022
From Benzinga
From Benzinga
Here's Why Longeveron Stock Jumped Higher on Wednesday
January 05, 2022
Tickers
LGVN
From Motley Fool
25 Stocks Moving In Tuesday's Mid-Day Session
December 28, 2021
From Benzinga
54 Biggest Movers From Thursday
December 27, 2021
From Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
December 23, 2021
From Benzinga
5 Short Squeeze Candidates To Watch: Petros Pharmaceuticals, iSpecimen Top The List Again
December 20, 2021
From Benzinga
The 10 Most Shorted Stocks Right Now for Friday, Dec. 17
December 17, 2021
From InvestorPlace
5 Short Squeeze Candidates To Watch: Petros Pharma Tops List With 254% Cost To Borrow, One Of Highest Figures On Record
December 13, 2021
From Benzinga
3 Predictions for the Stock Market in 2022
December 10, 2021
From InvestorPlace
Why Longeveron’s Good News Isn’t Telling Us the Whole Truth
December 10, 2021
Tickers
LGVN
From InvestorPlace
18 Stocks Moving in Friday's Pre-Market Session
December 10, 2021
From Benzinga
Mid-Morning Market Update: Markets Open Lower; US Initial Jobless Claims Drop To 52-Year Low
December 09, 2021
From Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
From InvestorPlace
2 Big Stock Bets That Are Insiders Are Buying Now
December 06, 2021
From InvestorPlace
Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS)
December 06, 2021
Tickers
LGVN
From Benzinga
58 Biggest Movers From Friday
December 06, 2021
From Benzinga
Is Longeveron a Good Biotech Stock to Buy?
December 05, 2021
From Motley Fool
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
December 03, 2021
From Benzinga
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings
December 03, 2021
From Benzinga
41 Stocks Moving In Friday's Mid-Day Session
December 03, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.